Annals of Intensive Care volume 12 , Article number: 84 Cite this article. Metrics details. Among strategies that aimed to prevent acquired infections AIs , selective decontamination regimens have been poorly studied in the COVID setting.
We performed an ancillary analysis of a multicenter retrospective observational study in 15 ICUs in western France. In addition to standard-care SC , 3 ICUs used MSD, a variant of selective digestive decontamination, which consists of the administration of topical antibiotics four times daily in the oropharynx and the gastric tube, chlorhexidine body wash and a 5-day nasal mupirocin course.
Due to missing data in patients, patients were finally included of whom 89 received MSD. Hospital mortality was lower in the MSD group Despite increased knowledge regarding severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 epidemic, intensivists have to face a surge of critically ill patients worldwide and mechanical ventilation remained an inescapable lifesaving therapy.
To our knowledge, selective digestive decontamination has been rarely studied in the COVID setting [ 9 , 10 , 11 ]. Of note, two studies reported survival benefit [ 10 , 11 ]. Therefore, we conducted an observational study to assess the impact of a selective digestive decontamination regimen on acquired infections and survival in ICU COVID patients.
We hypothesized that this strategy could be associated with a reduction of the incidence of VAP and BSI but also with a reduced mortality rate. Additional patients in the Vannes and SaintβBrieuc centers were included between June the 1st and December 31th Patients under liberty deprivation i.
